Robert G. Shawah
CIK 1601121 · Chief Financial Officer · last filed 2026-04-22
Robert G. Shawah is a Chief Financial Officer who has filed 10 SEC Form 4 insider transactions across 4 companies since 2014. The most recent filing, for ACXP, was dated Apr 22, 2026. Across all open-market trades the lifetime net is +$6.0K, making them a net buyer over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
4
10
$6.0K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ACXP | Chief Financial Officer | — | $1.57 | — | $0 | 5 | 2026-04-22 |
| Enveric Biosciences, Inc. (AMRHW) Delisted | Director | 400 | — | — | $0 | 1 | 2018-08-22 |
| PLx Pharma Inc. (PLXP) Delisted | Chief Accounting Officer | — | $0.09 | — | $0 | 1 | 2017-04-20 |
| PLx Pharma Inc. (DPRX) Delisted | Chief Accounting Officer | 500 | — | — | $6.0K | 3 | 2016-01-21 |
Recent Filings
10 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-04-22 | ACXP | Grant (A) | — | $0 | EDGAR |
| 2025-02-06 | ACXP | Grant (A) | — | $0 | EDGAR |
| 2024-04-03 | ACXP | Grant (A) | — | $0 | EDGAR |
| 2023-02-24 | ACXP | Grant (A) | — | $0 | EDGAR |
| 2021-07-06 | ACXP | Grant (A) | — | $0 | EDGAR |
| 2018-08-22 | Enveric Biosciences, Inc. (AMRHW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-04-20 | PLx Pharma Inc. (PLXP) Delisted | Grant (A) | — | $0 | EDGAR |
| 2016-01-21 | PLx Pharma Inc. (DPRX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2015-01-29 | PLx Pharma Inc. (DPRX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2014-03-19 | PLx Pharma Inc. (DPRX) Delisted | Mixed | +500 | $6.0K | EDGAR |